Phase 2b, Double-Blind, Parallel-group Study of S-2367 in Obese Patients
Phase 2
- Conditions
- Obesity (BMI: >=25.0) with glucose intolerance or type 2 diabetes and dyslipidemia
- Registration Number
- JPRN-jRCT2080221761
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 280
Inclusion Criteria
Main inclusion criteria
1. With BMI >=25.0
2. With visceral fat area >=100 cm2 as determined with abdominal CT
3. Previously diagnosed with glucose intolerance or type 2 diabetes,
and HbA1c (NGSP) >=6.5% to <9.4%
4. Previously diagnosed as dyslipidemia with fasting serum triglycerides >=150 mg/dL
and/or fasting serum HDL-cholesterol <40 mg/d
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent change in body weight
- Secondary Outcome Measures
Name Time Method